A&O Shearman advises InVivo on public tender offer and mandatory squeeze-out of Teract

"A&O Shearman advised InVivo on its public tender offer and subsequent mandatory squeeze-out of Teract. The offer, filed with the AMF on 5 February 2026 in concert with the three founders of SPAC 2MX Organic, led to InVivo acquiring all Teract shares and securities following completion in early June 2026."

A&O Shearman advised InVivo, one of the leading European agricultural groups, in connection with its public tender offer followed by a mandatory squeeze-out of Teract. Teract originated from the combination of SPAC 2MX Organic, created by Xavier Niel, Mathieu Pigasse and Moez-Alexandre Zouari (founder of Picard Surgelés), with InVivo's retail activities to create a sustainable and responsible retail player. On February 5, 2026, InVivo, acting in concert with the three founders of 2MX Organic, filed a public tender offer with the Autorité des marchés financiers (AMF) for all Teract shares and listed securities not already owned by them. The mandatory squeeze-out of minority shareholders took place in early June 2026. Following completion of the squeeze-out, InVivo acquired all Teract shares and other securities held by the three founders. A&O Shearman represented InVivo with a team composed by: Frederic Moreau, Partner, Paris; Marc Castagnede, Partner, Paris; Catherine Maison-Blanche, Senior Consultant, Paris; Antoine Messent, Associate, Paris; Aresse Chegra, Associate, Paris; Charles del Valle, Partner, Paris; Thibault Faivre-Pierret, Senior Associate, Paris.

Menu

A&O Shearman advises InVivo on public tender offer and mandatory squeeze-out of Teract

Read the full story

Menu

A&O Shearman advises InVivo on public tender offer and mandatory squeeze-out of Teract

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads